AV411

· Avigen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AV411, covering 2007-12-19 to 2016-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal [Phase 2]